MacroGenics, Inc.

Rockville,  MD 
United States
http://www.macrogenics.com

• Booth: 24159

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains.

Brands: See email to Samantha for 1140 x 250 Banner attachment

 Press Releases

• MacroGenics Pipeline (Apr 16, 2021)

  https://www.macrogenics.com/pipeline/

• MARGENZA TM (margetuximab-cmkb) (Apr 16, 2021)

  www.margenza.com

• PI, including Boxed Warning (Apr 16, 2021)
  See document attached to Email to Samantha

• MARGENZA Fact Sheet (Apr 16, 2021)
  See document attached to email to Samantha

• MARGENZA Patient Support (Apr 16, 2021)
  See document attcahed to email to Samantha

 Products